Several international pharmaceutical firms discussed investing in Saudi Arabia with King Abdullah Economic City’s (KAEC) Industrial Valley, Al-Eqtisadiah newspaper reported, citing Industrial Valley’s CEO Ayman Mansy.
The Industrial Valley continues to aim for attracting renowned pharma plants to invest in Saudi Arabia, he said.
More than 116 companies from various sectors are working in the Industrial Valley, including pharmaceuticals, he said.
Pharmaceutical imports declined to 75 percent from 80 percent in 2015, attributed to the increase in localizing pharma industry in the Saudi market.
The size of Saudi’s pharmaceutical market reaches $8 billion, the region’s largest market.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}